China Pharma Holdings, Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2011
Total Assets: $156.4M
Liabilities Breakdown FY2011
Total Liabilities: $13.9M
Asset Breakdown
Total Assets: $156.4M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $4.1M | 2.6% |
| Accounts Receivable | $69.7M | 44.6% |
| Inventory | $30.4M | 19.4% |
| Property, Plant & Equipment | $6.3M | 4.1% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $3.1M | 2.0% |
| Other Assets | $42.8M | 27.4% |
Liabilities Breakdown
Total Liabilities: $13.9M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $3.1M | 22.4% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $10.8M | 77.6% |